Phase
Condition
Primary Biliary Cholangitis
Treatment
Bioimpedence Vector Analysis
Clinical Study ID
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female volunteers aged ≥18 to ≤80 years at the date of signing the informedconsent.
Willingness and ability to provide written, personally signed, and dated informedconsent, in accordance with the latest ICH Good Clinical Practice (GCP) Guidelinesand applicable regulations.
An understanding, ability and willingness to fully comply with project proceduresand restrictions.
For PART B only:
With a known history of MASLD as evidenced either of:
GP diagnosis on HCF
Documented Fibroscan or liver US demonstrating MASLD
Exclusion
Exclusion Criteria:
Known alcoholic liver disease, history of cirrhosis of any other cause (metabolic,viral hepatitis or other)
Any other significant previous liver pathology (liver malignancy, portalhypertension, infiltrative liver disease)
Alcohol consumption >30 units per week
An Implanted cardiac devices
Study Design
Study Description
Connect with a study center
Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
London, SE1 1YR
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.